Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment (2023)
- Authors:
- USP affiliated authors: DAGLI, MARIA LUCIA ZAIDAN - FMVZ ; GOMES, CRISTINA DE OLIVEIRA MASSOCO SALLES - FMVZ ; KFOURY JUNIOR, JOSÉ ROBERTO - FMVZ ; SORKHABI, PARVIZ AZIMNASAB - FMVZ ; ASL, MARYAM SOLTANI - FMVZ
- Unidade: FMVZ
- DOI: 10.1007/s11033-023-08469-3
- Subjects: NEOPLASIAS; ENZIMAS; IMUNOSSUPRESSÃO
- Keywords: IDO; kynurenine; IDO inhibitor; immunosuppression; cancer; tumor microenvironment
- Language: Inglês
- Imprenta:
- Source:
- Título: Molecular Biology Reports
- ISSN: 0301-4851
- Volume/Número/Paginação/Ano: v. 50, p. 6133-6145, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
AZIMNASAB‐SORKHABI, Parviz et al. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports, v. 50, p. 6133-6145, 2023Tradução . . Disponível em: https://doi.org/10.1007/s11033-023-08469-3. Acesso em: 09 jan. 2026. -
APA
Azimnasab‐sorkhabi, P., Soltani‐asl, M., Yoshinaga, T. T., Dagli, M. L. Z., Gomes, C. de O. M. -S., & Kfoury Junior, J. R. (2023). Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports, 50, 6133-6145. doi:10.1007/s11033-023-08469-3 -
NLM
Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Dagli MLZ, Gomes C de OM-S, Kfoury Junior JR. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment [Internet]. Molecular Biology Reports. 2023 ; 50 6133-6145.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1007/s11033-023-08469-3 -
Vancouver
Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Dagli MLZ, Gomes C de OM-S, Kfoury Junior JR. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment [Internet]. Molecular Biology Reports. 2023 ; 50 6133-6145.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1007/s11033-023-08469-3 - The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells
- IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells
- Landscape of unconventional γδ T cell subsets in cancer
- Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) as an undetermined tool in tumor cells
- The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran
- The role of IDO enzyme on the expression of CTLA-4 immune checkpoint on the T lymphocyte cells in mammary câncer
- Evaluation the role of the IDO-kyn-AHR pathway on T cells and macrophages in the breast tumor microenvironment
- Inhibitory effects of a reengineered anthrax toxin on canine and human osteosarcoma cells
- Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first study
- Intratumoral (Poly-ICLC) therapy for dogs with advanced cancers: first report on clinical effectiveness, quality of life, and adverse events
Informações sobre o DOI: 10.1007/s11033-023-08469-3 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
DAG_1402_3136926_R.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
